Power Nickel Inc. (TSXV: PNPN) (OTCQB: PNPNF) reported strong drill results from its fall 2024 campaign, with Hole PN-24-095a returning 10.60% CuEq over 5.35m within 3.61% CuEq over 19.40m, confirming a high-grade extension in the Lion Zone. These assays validate the interpreted plunge extension below previous drill holes, reinforcing the project’s potential as a major nickel-copper-PGE deposit in Canada. Read Entire News Release.
Gold Terra Resource Corp. (TSXV: YGT) (OTCQB: YGTFF) has released the latest advancements in its exploration activities and corporate strategy. The company continues to strengthen its position in the gold mining sector through its ongoing development of the Con Mine Option Property and other key assets in the Yellowknife mining district.
Key Highlights from the Fact Sheet
The company remains committed to leveraging its expertise and strategic partnerships to unlock the full potential of its assets, positioning itself as a leading player in the North American gold mining industry.Gold Terra is focused on the exploration and development of gold properties in Canada’s Northwest Territories. With its extensive land package and proximity to historical high-grade gold production, the company aims to revitalize the Yellowknife gold camp while delivering strong returns to shareholders. For a detailed look see: Gold Terra Resource Corp. February 2025 Fact Sheet
Stocks in the News Today
Oragenics, Inc. (NYSE American: OGEN) announced that Dr. James P. Kelly, Chief Medical Officer and expert in concussion and brain health, will be a featured panelist at the 12th Annual Brain Health Summit on February 8, 2025, in New Orleans, coinciding with Super Bowl festivities. The event will highlight TBI prevention, treatment innovations, and athlete brain health, aligning with Oragenics’ work on ONP-002, an intranasal neurosteroid therapy for concussions. Read Entire News Release
Pasithea Therapeutics Corp. (NASDAQ: KTTA) announced that its Phase 1 clinical trial of PAS-004, a next-generation MEK inhibitor for advanced cancer and neurofibromatosis type 1 (NF1), has received Safety Review Committee (SRC) approval to escalate to the 22mg capsule dose. No dose-limiting toxicities (DLTs) or rash—a common side effect of MEK inhibitors—have been observed in the first 14 patients, reinforcing PAS-004’s favorable safety profile. The company anticipates sharing updated pharmacokinetic (PK) and pharmacodynamic (PD) data in Q1 2025. Read Entire News Release
Cyngn Inc. (Nasdaq: CYN) has secured a contract to deploy its DriveMod Tugger at a leading Consumer Packaged Goods (CPG) distribution company, reinforcing its growing role in automated logistics. This move highlights the adaptability of Cyngn’s Enterprise Autonomy Suite (EAS) in streamlining intra-facility transportation. CEO Lior Tal emphasized the significant automation opportunities in the CPG sector, where only one-third of companies utilize robotics in over 50% of operations. Powered by AI-driven safety features, DriveMod Tuggers integrate seamlessly with Cyngn Insight, providing real-time fleet management for optimized efficiency.
For investors seeking emerging opportunities in gold exploration, critical minerals, biotechnology advancements, and industrial automation, Gold Terra (TSXV: YGT), Power Nickel (TSXV: PNPN), Oragenics (NYSE American: OGEN), Pasithea Therapeutics (NASDAQ: KTTA), and Cyngn (Nasdaq: CYN) continue to deliver high-impact developments shaping their respective industries. Stay informed with the latest market-moving news, stock updates, and industry insights to identify the next big investment opportunities.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media ContactCompany Name: The Street ReportsContact Person: EditorEmail: Send EmailCountry: United StatesWebsite: http://www.thestreetreports.com
